KYMR
#967
Kymera Therapeutics, Inc. - Common Stock
110.4 0 USD
-0.07%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-7.50%
Monthly Change
+27.97%
6 month change
+46.48%
Year Change
+86.80%
Previous Close
119.3 5
Open
110.4 0
Low
110.4 0
High
110.4 0
Volume
142
Financials
- Market Capitalization 9.08 B
- Employee 253
- Founded 2015
- CEO N/A
- Website www.kymeratx.com
- Headquarter Delaware, United States
- FIGI BBG00SDHC8D1
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-21.09
Price to sales ratio
167.66
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 948 |  IONS Ionis Pharmaceuticals, Inc. - Common Stock | 56.75 USD | -2.58% | -32.78% | -22.78% | -21.32% | 9.38 B USD | ||
| 959 |  CORT Corcept Therapeutics Incorporated - Common Stock | 85.90 USD | -6.51% | -6.98% | +3.61% | +17.08% | 9.22 B USD | ||
| 968 |  HALO Halozyme Therapeutics, Inc. - Common Stock | 76.11 USD | -0.12% | -6.56% | +8.54% | +13.94% | 9.03 B USD | ||
| 983 |  CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 83.67 USD | +0.11% | +0.11% | +141.96% | +103.58% | 8.82 B USD |
Frequently asked questions about Kymera Therapeutics, Inc. - Common Stock
What is the Kymera Therapeutics, Inc. - Common Stock stock price today?
The current price of Kymera Therapeutics, Inc. - Common Stock (KYMR) is 110.4. Over the past 24 hours, the stock has changed by -7.50%. Follow the KYMR chart for real-time price dynamics.
What is the stock ticker of Kymera Therapeutics, Inc. - Common Stock?
Kymera Therapeutics, Inc. - Common Stock trades under the ticker KYMR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Kymera Therapeutics, Inc. - Common Stock stock going up?
KYMR has changed by -4.18% over the last week, +27.97% over the last month, and +86.80% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Kymera Therapeutics, Inc. - Common Stock net income for the last quarter?
Kymera Therapeutics, Inc. - Common Stock reported net income of -69.23 M for the last quarter. The previous quarter showed -86.98 M, which means net income changed by +20.40%.
How many employees does Kymera Therapeutics, Inc. - Common Stock have?
As of the latest available data, Kymera Therapeutics, Inc. - Common Stock has 253 employees. Workforce size can provide additional context about the company's scale and operations.
What is Kymera Therapeutics, Inc. - Common Stock EBITDA?
Kymera Therapeutics, Inc. - Common Stock EBITDA is -116.5 M, and its EBITDA margin is -339%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Kymera Therapeutics, Inc. - Common Stock stock?
You can buy Kymera Therapeutics, Inc. - Common Stock (KYMR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Kymera Therapeutics, Inc. - Common Stock stock?
Investing in Kymera Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KYMR chart and related analysis on metatrader.com as part of your research.